• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性限制性心肌病是心肌肌钙蛋白I突变临床表型的一部分。

Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.

作者信息

Mogensen Jens, Kubo Toru, Duque Mauricio, Uribe William, Shaw Anthony, Murphy Ross, Gimeno Juan R, Elliott Perry, McKenna William J

机构信息

Department of Cardiological Sciences, St. George's Hospital Medical School, Tooting, London, United Kingdom.

出版信息

J Clin Invest. 2003 Jan;111(2):209-16. doi: 10.1172/JCI16336.

DOI:10.1172/JCI16336
PMID:12531876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC151864/
Abstract

Restrictive cardiomyopathy (RCM) is an uncommon heart muscle disorder characterized by impaired filling of the ventricles with reduced volume in the presence of normal or near normal wall thickness and systolic function. The disease may be associated with systemic disease but is most often idiopathic. We recognized a large family in which individuals were affected by either idiopathic RCM or hypertrophic cardiomyopathy (HCM). Linkage analysis to selected sarcomeric contractile protein genes identified cardiac troponin I (TNNI3) as the likely disease gene. Subsequent mutation analysis revealed a novel missense mutation, which cosegregated with the disease in the family (lod score: 4.8). To determine if idiopathic RCM is part of the clinical expression of TNNI3 mutations, genetic investigations of the gene were performed in an additional nine unrelated RCM patients with restrictive filling patterns, bi-atrial dilatation, normal systolic function, and normal wall thickness. TNNI3 mutations were identified in six of these nine RCM patients. Two of the mutations identified in young individuals were de novo mutations. All mutations appeared in conserved and functionally important domains of the gene. This article was published online in advance of the print edition. The date of publication is available from the JCI website, http://www.jci.org.

摘要

限制性心肌病(RCM)是一种罕见的心肌疾病,其特征是在心室壁厚度正常或接近正常且收缩功能正常的情况下,心室充盈受损且容积减小。该疾病可能与全身性疾病有关,但最常见的是特发性的。我们识别出一个大家族,其中一些个体患有特发性RCM或肥厚型心肌病(HCM)。对选定的肌节收缩蛋白基因进行连锁分析后,确定心肌肌钙蛋白I(TNNI3)为可能的致病基因。随后的突变分析发现了一种新的错义突变,该突变在家族中与疾病共分离(连锁值:4.8)。为了确定特发性RCM是否是TNNI3突变临床表型的一部分,我们对另外9名无亲缘关系的RCM患者进行了该基因的遗传学研究,这些患者具有限制性充盈模式、双房扩大、收缩功能正常且心室壁厚度正常。在这9名RCM患者中有6名发现了TNNI3突变。在年轻个体中发现的两个突变是新发突变。所有突变均出现在该基因的保守且功能重要的结构域中。本文已先于印刷版在线发表。发表日期可从JCI网站(http://www.jci.org)获取。

相似文献

1
Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.特发性限制性心肌病是心肌肌钙蛋白I突变临床表型的一部分。
J Clin Invest. 2003 Jan;111(2):209-16. doi: 10.1172/JCI16336.
2
Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.南非限制性心肌病和局灶性心室肥厚患者的诊断差异以及两个TNNI3基因突变的鉴定,其中一个为新发现的突变,另一个为新发突变。
Cardiovasc J Afr. 2015 Mar-Apr;26(2):63-9. doi: 10.5830/CVJA-2015-019.
3
Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.儿童特发性限制性心肌病由心脏肌节蛋白基因突变引起。
Heart. 2008 Nov;94(11):1478-84. doi: 10.1136/hrt.2007.134684. Epub 2008 May 8.
4
Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy.特发性限制型心肌病伴或不伴肥厚的印度患者的遗传和临床特征。
Mol Cell Biochem. 2009 Nov;331(1-2):187-92. doi: 10.1007/s11010-009-0157-7. Epub 2009 May 17.
5
[Clinical characteristics and genetic analysis of three pediatric patients with idiopathic restrictive cardiomyopathy].三名特发性限制型心肌病患儿的临床特征及基因分析
Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Apr;41(4):304-9.
6
Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy.肌钙蛋白I、心脏舒张功能障碍与限制型心肌病
Acta Pharmacol Sin. 2004 Dec;25(12):1569-75.
7
Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.具有限制性表型的肥厚型心肌病的患病率、临床意义及遗传基础。
J Am Coll Cardiol. 2007 Jun 26;49(25):2419-26. doi: 10.1016/j.jacc.2007.02.061. Epub 2007 Jun 11.
8
Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.748例肥厚型心肌病连续家系中心脏肌钙蛋白I突变的频率及临床表型
J Am Coll Cardiol. 2004 Dec 21;44(12):2315-25. doi: 10.1016/j.jacc.2004.05.088.
9
Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology.家族性心肌病伴可变重塑和限制性生理学中的心肌肌钙蛋白T突变
Clin Genet. 2008 Nov;74(5):445-54. doi: 10.1111/j.1399-0004.2008.01062.x. Epub 2008 Jul 21.
10
Impaired Relaxation in Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Pathogenic Mutation of Pediatric Restrictive Cardiomyopathy.诱导多能干细胞衍生的心肌细胞中致病性小儿限制型心肌病突变导致的舒张功能障碍。
J Am Heart Assoc. 2024 Mar 19;13(6):e032375. doi: 10.1161/JAHA.123.032375. Epub 2024 Mar 18.

引用本文的文献

1
Troponin I - a comprehensive review of its function, structure, evolution, and role in muscle diseases.肌钙蛋白I——对其功能、结构、进化及在肌肉疾病中的作用的全面综述。
Anim Cells Syst (Seoul). 2025 Jul 28;29(1):446-468. doi: 10.1080/19768354.2025.2533821. eCollection 2025.
2
Genetic Animal Models of Cardiovascular Pathologies.心血管疾病的遗传动物模型
Biomedicines. 2025 Jun 21;13(7):1518. doi: 10.3390/biomedicines13071518.
3
From Rare Genetic Variants to Polygenic Risk: Understanding the Genetic Basis of Cardiomyopathies.从罕见基因变异到多基因风险:理解心肌病的遗传基础。
J Cardiovasc Dev Dis. 2025 Jul 17;12(7):274. doi: 10.3390/jcdd12070274.
4
Exploring contractile protein mechanisms and target medications for cardiomyopathic patients with diastolic dysfunction.探索舒张功能障碍型心肌病患者的收缩蛋白机制及靶向药物。
Pediatr Discov. 2024 Mar 25;2(1):e60. doi: 10.1002/pdi3.60. eCollection 2024 Mar.
5
Induced Pluripotent Stem Cells in Cardiomyopathy: Advancing Disease Modeling, Therapeutic Development, and Regenerative Therapy.诱导多能干细胞在心肌病中的应用:推动疾病建模、治疗开发和再生治疗
Int J Mol Sci. 2025 May 22;26(11):4984. doi: 10.3390/ijms26114984.
6
Myocardial expression of connexin 43 in cats with hypertrophic and restrictive cardiomyopathy phenotype.肥厚型和限制型心肌病表型猫心肌中连接蛋白43的表达
Open Vet J. 2025 Mar;15(3):1244-1252. doi: 10.5455/OVJ.2025.v15.i3.16. Epub 2025 Mar 31.
7
The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic.心肌病的“帕多瓦分类”分为三组:肥厚型/限制型、扩张型/运动减弱型和瘢痕形成/致心律失常型。
Eur Heart J Suppl. 2025 Feb 19;27(Suppl 1):i73-i82. doi: 10.1093/eurheartjsupp/suae108. eCollection 2025 Feb.
8
Familial restrictive cardiomyopathy with novel missense variant of uncertain significance in the FLNC gene.家族性限制性心肌病,伴有FLNC基因中意义未明的新型错义变异。
ESC Heart Fail. 2025 Jun;12(3):2367-2370. doi: 10.1002/ehf2.15233. Epub 2025 Feb 6.
9
Hypertrophic Cardiomyopathy: New Clinical and Therapeutic Perspectives of an "Old" Genetic Myocardial Disease.肥厚型心肌病:一种“古老”的遗传性心肌病的新临床与治疗视角
Genes (Basel). 2025 Jan 10;16(1):74. doi: 10.3390/genes16010074.
10
Dilated Cardiomyopathy: A Genetic Journey from Past to Future.扩张型心肌病:从过去到未来的遗传之旅。
Int J Mol Sci. 2024 Oct 25;25(21):11460. doi: 10.3390/ijms252111460.

本文引用的文献

1
Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.与家族性肥厚型心肌病相关的肌钙蛋白I(R145G)突变的功能分析
J Biol Chem. 2002 Apr 5;277(14):11670-8. doi: 10.1074/jbc.M108912200. Epub 2002 Jan 18.
2
Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.在家族性肥厚型心肌病中发现的人类心肌肌钙蛋白I基因变异的功能后果。
J Mol Cell Cardiol. 2001 Dec;33(12):2095-107. doi: 10.1006/jmcc.2001.1473.
3
Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.肥厚型心肌病:心肌肌钙蛋白T疾病猝死的组织病理学特征
Circulation. 2001 Sep 18;104(12):1380-4. doi: 10.1161/hc3701.095952.
4
Development and application of linkage analysis in genetic diagnosis of familial hypertrophic cardiomyopathy.连锁分析在家族性肥厚型心肌病基因诊断中的发展与应用
J Med Genet. 2001 Mar;38(3):193-8. doi: 10.1136/jmg.38.3.193.
5
The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.心肌病的遗传基础:从突变识别到机制范式
Cell. 2001 Feb 23;104(4):557-67. doi: 10.1016/s0092-8674(01)00242-2.
6
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.肌节蛋白基因突变是扩张型心肌病的病因之一。
N Engl J Med. 2000 Dec 7;343(23):1688-96. doi: 10.1056/NEJM200012073432304.
7
Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy.与家族性肥厚型心肌病相关的心肌肌钙蛋白I突变的转基因建模
Circ Res. 2000 Oct 27;87(9):805-11. doi: 10.1161/01.res.87.9.805.
8
Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy.限制型心肌病患儿的猝死和心血管衰竭
Circulation. 2000 Aug 22;102(8):876-82. doi: 10.1161/01.cir.102.8.876.
9
Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.心肌肌钙蛋白I基因Lys183缺失突变所致肥厚型心肌病的临床特征
Circulation. 2000 Aug 8;102(6):663-9. doi: 10.1161/01.cir.102.6.663.
10
Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.导致肥厚型心肌病的人类心肌肌钙蛋白I突变体的调节特性改变。
J Biol Chem. 2000 Jul 21;275(29):22069-74. doi: 10.1074/jbc.M002502200.